Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
Launched by COLUMBIA UNIVERSITY · Sep 21, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help teenagers with Adolescent Idiopathic Scoliosis (AIS) by using a special device and smartphone app. The goal is to better understand how well patients are wearing their braces at home and to check if the braces fit properly. By collecting continuous data about the brace’s tension, doctors and patients can get more accurate information on how the brace is working and how to improve its use. The study will also see if sharing this information directly with the patients and their caregivers through the app can help them wear their braces more consistently.
To participate in this study, girls aged 12 to 18 who have been diagnosed with AIS and are recommended to wear a specific type of brace (Rigo bracing) may be eligible. However, those who have had previous spine surgery cannot participate. If you join the trial, you will receive the device and app to monitor your brace use, and you’ll be able to see how well you’re doing in real-time. This could help improve your treatment and ensure that your brace is providing the best support for your condition.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of Adolescent Idiopathic Scoliosis (AIS)
- • Sanders skeletal stage 4 or earlier
- • Clinician-recommended Rigo bracing
- • Patient receiving brace treatment
- Exclusion Criteria:
- • - Prior spine surgery
About Columbia University
Columbia University, a prestigious Ivy League institution located in New York City, is a leading sponsor of clinical trials dedicated to advancing medical research and improving patient care. With a robust network of research facilities and a commitment to innovation, Columbia University collaborates with a diverse range of healthcare professionals and researchers to explore groundbreaking therapies and treatment methodologies. The university's clinical trials encompass various fields, including oncology, neurology, and public health, aiming to translate scientific discoveries into effective clinical applications. Columbia University is dedicated to maintaining the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants while contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Benjamin Roye, MD, MPH
Principal Investigator
Columbia University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials